FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034682252> ?p ?o ?g. }

• W2034682252 endingPage "261" @default.
• W2034682252 startingPage "261" @default.
• W2034682252 abstract "AACR Centennial Conference: Translational Cancer Medicine-- Nov 4-8, 2007; SingaporeC61 Objectives: Superficial bladder cancers (SBC) have a 60-70% recurrence rate after transurethral resection, and 10-20% of recurrences progress to invasive cancer. Post-transurethral resection intravesical Bacillus Calmette-Guerin (BCG) instillation has been the ‘gold-standard’ treatment for high risk SBC, for which 20-40% of patients do not respond. There are also frequent, potentially serious side effects to BCG therapy. Although clinical and pathologic variables to predict BCG response and cancer recurrence have been extensively studied, little is known of the role of underlying host genetic susceptibility factors, such as genetic polymorphisms. The NRAMP1 gene has been implicated in susceptibility to tuberculosis and to BCG response in murine models. The Human glutathione peroxidase 1 (hGPX1) is a selenium-dependent enzyme that participates in detoxification of hydrogen peroxide, organic peroxides, and possibly cigarette smoke-derived oxidative radicals. An association between hGPX1 and NRAMP1, and bladder cancer recurrence has been suggested. We aim to determine the predictive value of NRAMP1 and hGPX1 gene polymorphisms in superficial bladder cancer recurrence and response to BCG therapy. Methods: Peripheral blood DNA was prospectively obtained from 99 high risk superficial bladder cancer patients, who underwent post-resection intravesical regimes of BCG (81mg, n=50 or 27mg, n=19) or BCG (27mg) with interferon alpha (IFNa) (n=30), and followed-up for a mean of 4.5 years. The (GT)n and D534N polymorphisms in the NRAMP1 gene, and the Pro198Leu polymorphism in the hGPX1 gene were tested with restriction fragment length polymorphisms and DNA sequencing following PCR amplification. Data was analyzed using Chi-square analysis, multiple logistic regression and Kaplan-Meier curves. Results: The D534N G:A genotype was found to be protective towards cancer recurrence (p=0.016) and cancer-specific death (p=0.036). The presence of allele 3 in the (GT)n gene polymorphism was found to correlate with higher recurrence in BCG treated patients (p=0.003), and had shorter recurrence-free survival (p=0.024) and progression-free survival (p=0.005) in patients treated with a combination of BCG and IFNa. The hGPX1 CC genotype was shown to be protective (p=0.014), while the variant CT genotype (Pro/Leu) was associated with increased bladder cancer recurrence and decreased time to recurrence (p=0.03) after BCG therapy. Conclusion: Our findings suggest that polymorpisms in the NRAMP1 and hGPX1 genes correlate with response to BCG therapy in bladder cancer patients. They may serve as molecular markers to predict BCG failure and cancer recurrence." @default.
• W2034682252 created "2016-06-24" @default.
• W2034682252 creator A5000431183 @default.
• W2034682252 creator A5018017324 @default.
• W2034682252 creator A5028518285 @default.
• W2034682252 creator A5066466578 @default.
• W2034682252 creator A5072434302 @default.
• W2034682252 creator A5084975407 @default.
• W2034682252 date "2010-04-01" @default.
• W2034682252 modified "2023-10-16" @default.
• W2034682252 title "818 HUMAN GENE POLYMORPHISM AND RESPONSE TO BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR SUPERFICIAL BLADDER CANCER" @default.
• W2034682252 doi "https://doi.org/10.1016/s1569-9056(10)60801-9" @default.
• W2034682252 hasPublicationYear "2010" @default.
• W2034682252 type Work @default.
• W2034682252 sameAs 2034682252 @default.
• W2034682252 citedByCount "0" @default.
• W2034682252 crossrefType "journal-article" @default.
• W2034682252 hasAuthorship W2034682252A5000431183 @default.
• W2034682252 hasAuthorship W2034682252A5018017324 @default.
• W2034682252 hasAuthorship W2034682252A5028518285 @default.
• W2034682252 hasAuthorship W2034682252A5066466578 @default.
• W2034682252 hasAuthorship W2034682252A5072434302 @default.
• W2034682252 hasAuthorship W2034682252A5084975407 @default.
• W2034682252 hasConcept C121608353 @default.
• W2034682252 hasConcept C126322002 @default.
• W2034682252 hasConcept C203014093 @default.
• W2034682252 hasConcept C2777701055 @default.
• W2034682252 hasConcept C2780352672 @default.
• W2034682252 hasConcept C2780674031 @default.
• W2034682252 hasConcept C2992454250 @default.
• W2034682252 hasConcept C502942594 @default.
• W2034682252 hasConcept C71924100 @default.
• W2034682252 hasConceptScore W2034682252C121608353 @default.
• W2034682252 hasConceptScore W2034682252C126322002 @default.
• W2034682252 hasConceptScore W2034682252C203014093 @default.
• W2034682252 hasConceptScore W2034682252C2777701055 @default.
• W2034682252 hasConceptScore W2034682252C2780352672 @default.
• W2034682252 hasConceptScore W2034682252C2780674031 @default.
• W2034682252 hasConceptScore W2034682252C2992454250 @default.
• W2034682252 hasConceptScore W2034682252C502942594 @default.
• W2034682252 hasConceptScore W2034682252C71924100 @default.
• W2034682252 hasIssue "2" @default.
• W2034682252 hasLocation W20346822521 @default.
• W2034682252 hasOpenAccess W2034682252 @default.
• W2034682252 hasPrimaryLocation W20346822521 @default.
• W2034682252 hasRelatedWork W2030612376 @default.
• W2034682252 hasRelatedWork W2261933510 @default.
• W2034682252 hasRelatedWork W2342065801 @default.
• W2034682252 hasRelatedWork W2893846263 @default.
• W2034682252 hasRelatedWork W2946377256 @default.
• W2034682252 hasRelatedWork W2973160925 @default.
• W2034682252 hasRelatedWork W2996772275 @default.
• W2034682252 hasRelatedWork W3084138469 @default.
• W2034682252 hasRelatedWork W3195008613 @default.
• W2034682252 hasRelatedWork W4214943367 @default.
• W2034682252 hasVolume "9" @default.
• W2034682252 isParatext "false" @default.
• W2034682252 isRetracted "false" @default.
• W2034682252 magId "2034682252" @default.
• W2034682252 workType "article" @default.